Sponsor Dashboard
Monitor your clinical trial portfolio and site network performance.
Active Trials
12
+2 this quarter
Currently running
Site Network
51
+5 new sites
Activated sites
Total Enrollment
1,240
+15% vs target
Across all trials
Data Quality
98.2%
+2.1% improvement
Average score
Enrollment Progress vs Target
Data Quality Trend
Active Trials
Cardiovascular Prevention Study
on-track
ID: TRIAL-2024-CV01Phase: Phase IIISites: 15Completion: Q4 2024
Enrolled
298/300
Diabetes Management Trial
behind
ID: TRIAL-2024-DM02Phase: Phase IISites: 8Completion: Q1 2025
Enrolled
156/200
Hypertension Treatment Study
completed
ID: TRIAL-2024-HT03Phase: Phase IIISites: 12Completion: Completed
Enrolled
180/180
Top Performing Sites
Memorial Health Partners
excellent
Boston, MAPI: Dr. Sarah JohnsonRetention: 99.2%
Enrolled
45/50
Advanced Research Group
good
New York, NYPI: Dr. Robert WilliamsRetention: 97.5%
Enrolled
38/40
Clinical Research Center
excellent
Chicago, ILPI: Dr. Maria GarciaRetention: 98.1%
Enrolled
42/45
Geographic Distribution
North America35 sites
Europe12 sites
Asia Pacific4 sites
Trial Phases
Phase I2 trials
Phase II4 trials
Phase III6 trials
Upcoming Milestones
DSMB Meeting
Jan 25, 2024
Interim Analysis
Feb 15, 2024
Database Lock
Mar 30, 2024